chartexchange

RDHL
Redhill Biopharma Ltd.
stockNASDAQADR

At CloseOct 30, 2026 4:37:30 PM EDT
0.3878USD-6.913%(-0.0288)109,223
Pre-marketOct 30, 2026 10:04:56 AM EDT
0.39USD-6.121%(-0.03)
Loading…
Loading…
Healthcare
Drug Manufacturers-Specialty & Generic
CEO
Dror Ben-Asher
HQ
Tel Aviv, Tel Aviv Yafo, Israel
Previous Close
$0.42
Beta
0.70
52-Week High
$1.60 2026-08-31
52-Week Low
$0.38 2026-10-30
SMA 50
$0.56
SMA 200
$0.81
Avg. Vol 10D
138,855
Avg. Vol 30D
658,291
Avg. Vol 90D
1.49M
Relative Vol
0.17
2.28M
49.4500%
6,356
Aug 20, 2024 · 1-for-25 (reverse)
RDHL Profile

redhill biopharma is a biopharmaceutical company focused primarily on development of late clinical-stage new, improved and patented formulations of existing drugs. redhill has an experienced management team, board of directors and advisory board based in israel, the us, canada and europe, with successful track record at big and small pharma of bringing patented drugs to the market, as well as extensive managerial, financial, and transactional expertise

RDHL Performance
PeriodPriceDateChangeBeta
1W0.422026-10-23-8.37%3.353
1M0.482026-10-01-19.21%1.731
3M0.652026-07-31-40.34%0.732
6M1.092026-05-01-64.26%0.150
1Y1.302025-10-31-70.17%0.698
2Y8.242024-10-31-95.29%—
5Y5,300.002021-11-01-99.99%1.038
RDHL Stock Summary

Redhill Biopharma Ltd. (NASDAQ:RDHL) stock price today is $0.39, and today's volume is 109,223. RDHL is down 6.913% today. The 30 day average volume is 658,291. RDHL market cap is $3.45M with 8.89M shares outstanding.